Velphoro® (sucroferric oxyhydroxide) – Expanded indication
July 1, 2024 - The FDA approved Fresenius’ Velphoro (sucroferric oxyhydroxide), for the control of serum phosphorus levels in adults and pediatric patients 9 years of age and older with chronic kidney disease (CKD) on dialysis.
Download PDF
